Leiden University Medical Center Mini Donor Bank

Asthma Clinical Trial

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02810613
• Other study ID #: Mini Donor Bank
• Status: Withdrawn
• Phase: N/A
• First received: May 31, 2016
• Last updated: August 28, 2017
• Start date: May 31, 2016
• Est. completion date: May 31, 2016

Study information

• Verified date: August 2017
• Source: Leiden University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

(Bio)medical research, particularly immunological, metabolic, transcriptional or biological assays, occasionally require the use of fresh blood (peripheral mononuclear cells) or urine. In order to comply with international guidelines for Good Clinical Practice, the investigators propose to establish a Mini Donor Bank to be able to obtain fresh blood or urine from voluntary donors. Recruitment of volunteers will be a continuous process. Volunteers will consent to occasional blood- or urine donation.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: May 31, 2016
• Est. primary completion date: May 31, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Subject is aged = 18 and = 65 years and in good health.

2. Subject has adequate understanding of the procedures of the study.

3. Subject is able to communicate well with the investigator.

4. Subject has signed informed consent.

5. Subject refrains from donation to the Sanquin blood bank.

Exclusion Criteria:

1. Previous vasovagal collapse during venepuncture.

2. For female participants: pregnancy or lactation.

3. Presence of any chronic systemic condition, which could compromise the health of the volunteer when performing venepuncture or interfere with the interpretation of immunological or metabolic test results.

4. Chronic use of immunosuppressive drugs.

5. Total blood volume donated exceeding >500 mL in the past 4 months.

Related Conditions & MeSH terms

• Asthma
• Diabetes
• Malaria
• Schistosoma Haematobium
• Schistosoma Mansoni

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Leiden University Medical Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	A collection of samples for the purpose of (bio)medical laboratory assays including immunological, metabolic, transcriptional or biological analyses.	collection of samples for the purpose of biomedical assays, e.g. biobanking of samples for different assays, each one of which has a separate objective	10 years